毒理学研究人员联盟2022年年度报告
Alexandra M Amaducci1, Sharan L Campleman2, Shao Li2
1Department of Emergency and Hospital Medicine, Lehigh Valley Health Network, 2545 Schoenersville Rd, Bethlehem, PA, 18017, USA.
概括
在2022年,阿片类止痛药成为报告到毒理学研究人员联盟 (ToxIC) 核心注册表的最常见的暴露剂. 这个国家病例注册表跟踪了医疗毒理学的患者咨询,治疗和结果.
科学领域:
- 医学毒理学医学毒理学
- 临床研究 临床研究
- 公共卫生监督 公共卫生监督
背景情况:
- 美国医学毒理学学院 (ACMT) 毒理学研究人员联盟 (ToxIC) 核心注册表收集有关患者咨询的全国数据.
- 该注册表记录了人口统计数据,暴露剂,临床发现,治疗和死亡率.
- 本报告详细介绍了第十三次年度数据提交,涵盖2022年.
研究的目的:
- 提交从2022年开始的毒性物质核注册表数据的第十三份年度报告.
- 确定最常见的暴露剂,并分析患者的治疗结果.
- 探索患者位置,远程医疗和成药物治疗的趋势.
主要方法:
- 在2022年,从35个参与站点的7206名患者收集的数据.
- 分析非识别患者数据,包括人口统计,暴露剂,临床征兆,症状,治疗和死亡率.
- 对患者住院位置,远程医疗和成药物治疗的描述性分析.
主要成果:
- 最常见的暴露剂类别是阿片类止痛药 (15.9%),其次是乙醇 (14.9%),非阿片类止痛药 (12.8%) 和抗抑郁药 (8.0%).
- 自注册开始以来,阿片类药物首次成为暴露的主要因素.
- 死亡人数为118人,致病率为1.6%.
结论:
- 阿片类止痛药已经成为报告到毒性物质核心注册表的暴露的主要原因.
- 该注册表继续为医学毒理学咨询和患者结果提供有价值的见解.
- 对患者位置,远程医疗和成药物治疗的进一步分析为数据提供了额外的背景.
相关概念视频
01:26Toxic Reactions: Overview
1.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
01:36Types of Toxins
1.8K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.8K
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
01:19Pharmacovigilance
886
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
183
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
183